BUCALA RICHARD J has a total of 11 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are ARIAD GENE THERAPEUTICS INC, MEDICAL RES COUNCIL and CROWN BIOSCIENCE TAICANG CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Foods and drinks | |
#5 | Agriculture | |
#6 | Environmental technology | |
#7 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Analysing materials | |
#7 | Animal care | |
#8 | Climate change adaptation technologies | |
#9 | Heterocyclic compounds | |
#10 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Bucala Richard J | 11 |
#2 | Leng Lin | 4 |
#3 | Metz Christine N | 4 |
#4 | Calandra Thierry F | 3 |
#5 | Bernhagen Jurgen | 3 |
#6 | Mitchell Robert A | 3 |
#7 | Cerami Anthony | 3 |
#8 | Jorgensen William | 1 |
#9 | Young Lawrence H | 1 |
#10 | Jorgensen William L | 1 |
Publication | Filing date | Title |
---|---|---|
US2014030266A1 | Methods of administering D-dopachrome tautomerase (D-DT) to treat ischemia-reperfusion injury | |
WO2011140202A2 | Mif modulators |